EMD Serono
FDA approves Pfizer and Merck KGaA’s Bavencio for maintenance of advanced bladder cancer
July 1, 2020Research and Development, Sales and Marketing Bavencio FDA, EMD Serono, Merck, Pfier
The FDA has moved to approve Bavencio (avelumab), developed by Pfizer and EMD Serono, the biopharma arm of Merck KGaA, …
Bavencio Phase 3 head and neck cancer trial terminated
March 16, 2020Research and Development, Sales and Marketing Bavencio, Cancer, EMD Serono, Merck KGaA, Pfizer, trial failure
Merck KGaA, its biopharma division EMD Serono, and Pfizer have announced their decision to terminate their ongoing Phase 3 trial …
Ariad names EMD Serono’s Paris Panayiotopoulos as new president and chief exec
December 21, 2015Sales and Marketing Ariad, Ariad Pharmaceuticals, EMD Serono, Paris Panayiotopoulos, harvey Berger
The board of directors at Ariad Pharmaceuticals has appointed Paris Panayiotopoulos as president and chief executive from 1 January 2016. …
Merck KGaA confirms leadership team appointments
June 20, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMD Serono, Merck KGaA, Serono
The subsidiary of Merck KGaA named EMD Serono has announced several appointments to its leadership team. The appointments include: Allene …
FDA knocks back Merck KGaA’s oral MS drug
March 2, 2011Sales and Marketing Cladribine, EMD Serono, FDA, MS, Merck KGaA, Movectro, multiple sclerosis, oral MS drugs
US authorities have turned down Merck KGaA’s new drug application for its oral relapsing-remitting multiple sclerosis treatment Movectro. The FDA …
FDA approves Merck’s HIV fat drug Egrifta
November 12, 2010Research and Development, Sales and Marketing EMD Serono, Egrifta, FDA, HIV, Merck KGaA, abdominal fat in HIV, tesamorelin
US regulatory authorities have approved the first treatment indicated to target abdominal fat in patients with HIV after trials showed …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
